HoldingsChannel.com
All Stocks Held By Acuta Capital Partners LLC
As of  12/31/2023, we find all stocks held by Acuta Capital Partners LLC to be as follows, presented in the table below with each row detailing each Acuta Capital Partners LLC position, ordered by largest to smallest position size. The all-stocks-held-by-Acuta Capital Partners LLC table shows the entity held in the first column (click any entity to explore other funds holding positions), the share amount held, the share count change between the last two reporting periods, and finally the position size for all stocks held by Acuta Capital Partners LLC as of the latest filing.

   EntityAmountChange
 09/30/2023 to 12/31/2023
Position Size
($ in 1000's)
RAYZEBIO INC 378,069 +33,498 $23,505
     RYZB378,069+33,498$23,505
CYMABAY THERAPEUTICS INC 492,155 +74,155 $11,625
     CBAY492,155+74,155$11,625
ROCKET PHARMACEUTICALS INC 366,015 +4,015 $10,969
     RCKT366,015+4,015$10,969
KURA ONCOLOGY INC 701,349 -744 $10,085
     KURA701,349-744$10,085
EYEPOINT PHARMACEUTICALS INC 425,128 +125,000 $9,825
     EYPT425,128+125,000$9,825
VAXCYTE INC 117,373 -3,649 $7,371
     PCVX117,373-3,649$7,371
SAREPTA THERAPEUTICS INC 70,600 +54,550 $6,808
     SRPT70,600+55,100$6,808
PRAXIS PRECISION MEDICINES I 299,636 -4,185,364 $6,676
     PRAX299,636-4,185,364$6,676
DISC MEDICINE INC 115,500 -22,698 $6,671
     IRON115,500-22,698$6,671
TAYSHA GENE THERAPIES INC 3,589,333 -238,593 $6,353
     TSHA3,589,333-238,593$6,353
VIRIDIAN THERAPEUTICS INC 281,500 +57,161 $6,131
     VRDN281,500+57,161$6,131
TOURMALINE BIO INC. 231,882 +231,882 $6,071
     TRML231,882+231,882$6,071
OCULAR THERAPEUTIX INC 1,310,000 +1,310,000 $5,843
     OCUL1,310,000+1,310,000$5,843
MERSANA THERAPEUTICS INC 2,368,000 +2,268,393 $5,494
     MRSN2,368,000+2,268,393$5,494
HILLEVAX INC 324,600 +54,281 $5,210
     HLVX324,600+54,281$5,210
IMMUNOVANT INC 119,489 -9,511 $5,034
     IMVT119,489-9,511$5,034
REVOLUTION MEDICINES INC 160,000 +160,000 $4,589
     RVMD160,000+160,000$4,589
APELLIS PHARMACEUTICALS INC 76,100 -168,384 $4,555
     APLS76,100-168,384$4,555
ARCELLX INC 77,000 +77,000 $4,274
     ACLX77,000+77,000$4,274
AADI BIOSCIENCES INC 1,849,402 UNCH $3,736
     AADI1,849,402UNCH$3,736
TERNS PHARMACEUTICALS INC 555,260 UNCH $3,604
     TERN555,260UNCH$3,604
CRINETICS PHARMACEUTICALS IN 87,500 -6,500 $3,113
     CRNX87,500-6,500$3,113
CELLDEX THERAPEUTICS INC 69,400 -52,941 $2,752
     CLDX69,400-52,941$2,752
AN2 THERAPEUTICS INC 132,000 +118,700 $2,705
     ANTX132,000+118,700$2,705
DYNE THERAPEUTICS INC 147,836 +1,336 $1,966
     DYN147,836+1,336$1,966
VERASTEM INC 232,249 +2,249 $1,891
     VSTM232,249+2,249$1,891
APPLIED THERAPEUTICS INC 525,100 +525,100 $1,759
     APLT525,100+525,100$1,759
ENLIVEN THERAPEUTICS INC 123,876 +20,276 $1,714
     ELVN123,876+20,276$1,714
4D MOLECULAR THERAPEUTICS INC 74,500 +74,500 $1,509
     FDMT74,500+74,500$1,509
LEAP THERAPEUTICS INC 354,166 UNCH $1,468
     LPTX354,166UNCH$1,468
CELLECTAR BIOSCIENCES INC 477,500 +356,200 $1,323
     CLRB477,500+356,200$1,323
INSMED INC 29,500 +29,500 $914
     INSM29,500+29,500$914
ARGENX SE ADR 2,400 +2,400 $913
     ARGX2,400+2,400$913
VERONA PHARMA PLC 19,000 +19,000 $378
     VRNA19,000+19,000$378
SPRINGWORKS THERAPEUTICS INC 10,000 +10,000 $365
     SWTX10,000+10,000$365
CENTESSA PHARMACEUTICALS PLC 38,138 -285,211 $304
     CNTA38,138-285,211$304
TYRA BIOSCIENCES INC 8,867 +8,867 $123
     TYRA8,867+8,867$123
NUVATION BIO      $5
     NUVB.WT90,832UNCH$5
ANAVEX LIFE SCIENCES CORP +0 $-22
     Put1,000+1,000$22
ACLARIS THERAPEUTICS $0 (exited)
     ACRS0-121,692$0
ALKERMES PLC $0 (exited)
     ALKS0-126,500$0
BRAINSTORM CELL THERAPEUTICS $0 (exited)
     Put0-2,500$0
BIOMEA FUSION INC $0 (exited)
     BMEA0-39,935$0
89BIO INC $0 (exited)
     Call0-1,000$0
     ETNB0-32,800$0
GLYCOMIMETIC INC $0 (exited)
     GLYC0-27,500$0
STRUCTURE THERAPEUTICS INC $0 (exited)
     GPCR0-5,000$0
IKENA ONCOLOGY INC $0 (exited)
     IKNA0-551,010$0
IONIS PHARMACEUTICALS INC $0 (exited)
     IONS0-11,300$0
KRONOS BIO INC $0 (exited)
     KRON0-718,739$0
MARINUS PHARMECEUTICALS INC $0 (exited)
     MRNS0-19,500$0
OLEMA PHARMACEUTICALS INC $0 (exited)
     OLMA0-153,007$0
REPLIMUNE GROUP INC $0 (exited)
     REPL0-150,000$0
     Call0-1,000$0
REZOLUTE INC $0 (exited)
     RZLT0-310,000$0
SYNDAX PHARMACEUTICALS INC $0 (exited)
     SNDX0-297,035$0
VENTYX BIOSCIENCES INC 0 -205,377 $0 (exited)
     VTYX0-205,377$0

See Summary: Acuta Capital Partners LLC Top Holdings
See Details: Top 10 Stocks Held By Acuta Capital Partners LLC

EntityShares/Amount
Change
Position Value
Change
TRML +231,882+$6,071
OCUL +1,310,000+$5,843
RVMD +160,000+$4,589
ACLX +77,000+$4,274
APLT +525,100+$1,759
FDMT +74,500+$1,509
INSM +29,500+$914
ARGX +2,400+$913
VRNA +19,000+$378
SWTX +10,000+$365
EntityShares/Amount
Change
Position Value
Change
VTYX -205,377-$7,133
REPL -151,000-$4,332
SNDX -297,035-$4,313
ALKS -126,500-$3,543
IKNA -551,010-$2,386
ETNB -33,800-$2,029
OLMA -153,007-$1,890
KRON -718,739-$934
ACRS -121,692-$834
BMEA -39,935-$550
EntityShares/Amount
Change
Position Value
Change
MRSN +2,268,393+$5,367
CLRB +356,200+$1,003
EYPT +125,000+$7,427
ANTX +118,700+$2,491
CBAY +74,155+$5,393
VRDN +57,161+$2,690
SRPT +54,550-$2,652
HLVX +54,281+$1,574
RYZB +33,498+$15,856
ELVN +20,276+$299
EntityShares/Amount
Change
Position Value
Change
PRAX -4,185,364-$993
CNTA -285,211-$1,788
TSHA -238,593-$5,743
APLS -168,384-$4,745
CLDX -52,941-$615
IRON -22,698+$178
IMVT -9,511+$82
CRNX -6,500+$317
PCVX -3,649+$1,201
Size ($ in 1000's)
At 12/31/2023: $177,653
At 09/30/2023: $149,213

Acuta Capital Partners LLC holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Acuta Capital Partners LLC 13F filings. Link to 13F filings: SEC filings

All Stocks Held By Acuta Capital Partners LLC | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.